| Genetic Tweak Helps Mice Avoid Cancer, Obesity: Study Posted: TUESDAY, March 6 (HealthDay News) -- New research offers potential insight into the connection between cancer, obesity and longevity in humans by showing that genetically modified mice live longer, skinnier and almost cancer-free lives. |
| Convenient cupcakes are dangerous for dieters Posted:  Sprinkles, the Beverly Hills bakery that helped inspire the craze for sweet frosting in snack-size portions, will launch a cupcake dispensing machine at its flagship store.
|
| Weight-Loss Surgery Seems Safe for Kidney Disease Patients Posted: THURSDAY, March 1 (HealthDay News) -- Obese chronic kidney disease patients who undergo surgery to achieve weight loss do not face a particularly dangerous rate of complications as a result, a new study suggests. |
| Nutrition labels now on meat packages Posted: WASHINGTON (Reuters) - Consumers who have ever puzzled about whether their T-bone steak is worth the calories can put their minds at ease. Starting Thursday, those nutrition labels found on almost all packaged foods can be found for ground meat and poultry. Forty of the most popular whole, raw cuts or meat and poultry, such as chicken breast or steak, also will have nutritional information either on the package labels or on display at the store, under a new Department of Agriculture rule. ... |
| Disney's Epcot retooling childhood obesity exhibit; critics say it's insensitive Posted: ORLANDO, Fla. - Walt Disney World is retooling an Epcot exhibit on childhood obesity after critics complained it was insensitive to obese kids and reinforced stereotypes. |
| Peer pressure drives "socially transmitted" anorexia Posted: LONDON (Reuters) - Anorexia is a socially transmitted disorder and appears to be more prevalent in countries such as France where women are thinner than average, according to new research from the London School of Economics and Political Science (LSE). The "economic analysis" of anorexia, using a sample of nearly 3,000 young women across Europe, concluded that peer group pressure is one of the most significant influences on self-image and the development of anorexia and appeared just as the autumn/winter season is winding up with Paris Fashion Week. ... |
| Peer pressure drives "socially transmitted" anorexia Posted: LONDON (Reuters) - Anorexia is a socially transmitted disorder and appears to be more prevalent in countries such as France where women are thinner than average, according to new research from the London School of Economics and Political Science (LSE). The "economic analysis" of anorexia, using a sample of nearly 3,000 young women across Europe, concluded that peer group pressure is one of the most significant influences on self-image and the development of anorexia and appeared just as the autumn/winter season is winding up with Paris Fashion Week. ... |
| Disney retooling obesity exhibit after complaints Posted: Walt Disney World says it is retooling an Epcot exhibit on childhood obesity after critics complained that it was insensitive to obese kids. |
| Obesity Linked to Asthma in Children Posted: WEDNESDAY, Feb. 29 (HealthDay News) -- Children and teens who are overweight or obese are more likely to have asthma than their healthy-weight peers, a new study finds. |
| Many Gaps in Fast-Food Nutrition Information Posted: TUESDAY, Feb. 28 (HealthDay News) -- Even when fast-food restaurants list calorie counts for menu items, diners may still have a hard time using the information to make healthy meal choices, researchers report. |
| Clamor for obesity pill may test FDA limits Posted: WASHINGTON (Reuters) - U.S. drug regulators may have a hard time stopping millions of overweight Americans from taking a new obesity drug that many are likely to view as a miracle pill for slimming waistlines, despite its safety risks. Regulators and doctors are hoping they can limit the pill, called Qnexa, to only those patients that need it most, helping fight the nation's obesity epidemic while avoiding exposing people to unnecessary risks of birth defects and heart problems. ... |
| Analysis: Clamor for obesity pill may test FDA limits Posted: WASHINGTON (Reuters) - U.S. drug regulators may have a hard time stopping millions of overweight Americans from taking a new obesity drug that many are likely to view as a miracle pill for slimming waistlines, despite its safety risks. Regulators and doctors are hoping they can limit the pill, called Qnexa, to only those patients that need it most, helping fight the nation's obesity epidemic while avoiding exposing people to unnecessary risks of birth defects and heart problems. ... |
| World Chefs: New cookbook spills the beans ... on beans Posted:  NEW YORK (Reuters) - Award-winning cookbook author Crescent Dragonwagon knows a lot about beans -- all kinds of beans, and how to use them to create everything from soups and salads to stews and curries and even cookies and ice cream. Her latest cookbook, "Bean by Bean," contains 175 recipes for meat and vegetarian meals, as well as the basics about different beans and their origins, and selecting, preparing, cooking and storing them. ...
|
| Fat cat's weight loss challenge makes Tiny an international celebrity Posted: FREDERICTON - Losing weight is hard enough, but try doing it with the world watching and when you'd rather be dreaming of mice. |
| Dieting Can Prove Dangerous for Kidney Disease Patients Posted: FRIDAY, Feb. 24 (HealthDay News) -- Overweight or obese people with chronic kidney disease may suffer further kidney damage if they use certain weight-loss methods, a new study warns. |
| Miracle diet pill? A safe drug is elusive Posted:  The battle of the bulge has been a big, fat failure for U.S. drugmakers. But that hasn't stopped them from trying.
|
| 3 weight loss drugs make 2nd bid for approval Posted: The Food and Drug Administration has rejected three prescription diet pills in the last three years, raising questions of whether any weight loss drug can win approval in the U.S. The agency has not approved a new prescription weight loss drug in 13 years. Historically, medications that attempt to burn fat or suppress appetite have been plagued by safety issues. |
| Experts say deep, complex causes of obesity may be beyond reach of weight loss drugs Posted: WASHINGTON - For nearly a century, scientists have struggled to make a diet pill that helps people lose weight without side effects that range from embarrassing digestive issues to dangerous heart problems. |
| Sector Snap: Diet drug makers gain on FDA advisory Posted: Shares of a trio of companies that are developing new weight-loss drugs climbed Thursday after a Food and Drug Administration panel recommended one of the drugs be approved. |
| Weight Watchers Intl starts Dutch tender offer Posted: Weight Watchers International Inc. is starting a modified Dutch tender offer for up to $720 million of its stock. |
| FDA Advisers Back Weight-Loss Drug Qnexa Posted: WEDNESDAY, Feb. 22 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel gave its blessing Wednesday to a highly anticipated weight loss pill that had been rejected by health advisers once before. |
| U.S. advisers back experimental obesity pill Posted: SILVER SPRING, Maryland (Reuters) - Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years. Vivus Inc's Qnexa was one of three promising obesity drugs rejected by the U.S. Food and Drug Administration in the past two years over safety concerns. It is the first to come back up for review after more extensive clinical trials, as public health officials urge the FDA to consider a medical treatment for a condition that affects about one-third of Americans. ... |
| U.S. advisers back experimental obesity pill Posted: SILVER SPRING, Maryland (Reuters) - Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years. Vivus Inc's Qnexa was one of three promising obesity drugs rejected by the U.S. Food and Drug Administration in the past two years over safety concerns. It is the first to come back up for review after more extensive clinical trials, as public health officials urge the FDA to consider a medical treatment for a condition that affects nearly one-third of Americans. ... |
| FDA panel backs previously rejected obesity pill Posted: A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the U.S. market in more than a decade. |
| US health experts give nod to new obesity drug Posted:  An advisory panel to the US Food and Drug Administration on Wednesday urged approval of a new obesity drug, Qnexa, after warning against its approval in 2010 due to safety concerns.
|
